PTC Therapeutics, Inc. (PTCT) Social Stream
PTC THERAPEUTICS INC (PTCT) Price Targets From Analysts
Use the tables below to see what analysts covering PTC THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 8 | $85 | $38 | $58.625 | $27.9 | 110.13% |
| 2022-01-30 | 8 | $70 | $38 | $54.857 | $27.9 | 96.62% |
| 2022-02-22 | 8 | $70 | $34 | $54.285 | $27.9 | 94.57% |
| 2022-03-09 | 8 | $76 | $34 | $55.142 | $27.9 | 97.64% |
| 2022-04-01 | 7 | $76 | $34 | $55.143 | $27.9 | 97.65% |
| 2022-04-04 | 7 | $76 | $34 | $55 | $27.9 | 97.13% |
| 2022-04-12 | 7 | $76 | $34 | $54.285 | $27.9 | 94.57% |
| 2022-04-19 | 7 | $76 | $33 | $54.142 | $27.9 | 94.06% |
| 2022-05-04 | 7 | $79 | $33 | $54.571 | $27.9 | 95.59% |
| 2022-05-10 | 7 | $78 | $32 | $54 | $27.9 | 93.55% |
| 2022-05-23 | 7 | $78 | $34 | $54.285 | $27.9 | 94.57% |
| 2022-06-02 | 7 | $63 | $34 | $52.142 | $27.9 | 86.89% |
| 2022-06-21 | 7 | $63 | $35 | $52.285 | $27.9 | 87.4% |
| 2022-07-13 | 7 | $65 | $42 | $53.714 | $27.9 | 92.52% |
| 2022-08-08 | 7 | $69 | $42 | $54.714 | $27.9 | 96.11% |
| 2022-08-13 | 8 | $69 | $42 | $55.428 | $27.9 | 98.67% |
| 2022-09-01 | 9 | $70 | $42 | $57.25 | $27.9 | 105.2% |
| 2022-09-17 | 11 | $70 | $42 | $57.4 | $27.9 | 105.73% |
| 2022-10-12 | 11 | $70 | $42 | $57.5 | $27.9 | 106.09% |
| 2022-10-21 | 11 | $70 | $42 | $58.9 | $27.9 | 111.11% |
| 2022-10-28 | 11 | $70 | $36 | $56.9 | $27.9 | 103.94% |
| 2022-11-14 | 11 | $70 | $36 | $54.5 | $27.9 | 95.34% |
| 2023-01-09 | 12 | $70 | $35 | $52.727 | $27.9 | 88.99% |
| 2023-01-17 | 12 | $70 | $35 | $52.636 | $27.9 | 88.66% |
| 2023-02-01 | 12 | $70 | $35 | $52.909 | $27.9 | 89.64% |
| 2023-02-08 | 12 | $70 | $35 | $53.818 | $27.9 | 92.9% |
| 2023-02-22 | 12 | $70 | $35 | $54.09 | $27.9 | 93.87% |
| 2023-02-23 | 12 | $70 | $35 | $53.454 | $27.9 | 91.59% |
| 2023-03-09 | 12 | $75 | $35 | $54.272 | $27.9 | 94.52% |
| 2023-04-12 | 13 | $75 | $35 | $53.75 | $27.9 | 92.65% |
| 2023-04-18 | 13 | $75 | $35 | $54.666 | $27.9 | 95.94% |
| 2023-04-25 | 13 | $75 | $35 | $55.166 | $27.9 | 97.73% |
| 2023-04-28 | 13 | $75 | $35 | $54.166 | $27.9 | 94.14% |
| 2023-05-01 | 13 | $71 | $35 | $54.083 | $27.9 | 93.85% |
| 2023-05-08 | 13 | $71 | $35 | $54.666 | $27.9 | 95.94% |
| 2023-05-18 | 14 | $77 | $37 | $57.076 | $27.9 | 104.57% |
| 2023-05-24 | 14 | $75 | $37 | $56.615 | $27.9 | 102.92% |
| 2023-06-06 | 14 | $75 | $37 | $55.384 | $27.9 | 98.51% |
| 2023-06-30 | 14 | $73 | $37 | $55.23 | $27.9 | 97.96% |
| 2023-07-11 | 14 | $73 | $37 | $55 | $27.9 | 97.13% |
| 2023-07-20 | 14 | $73 | $37 | $54.769 | $27.9 | 96.3% |
| 2023-07-28 | 14 | $73 | $37 | $54.538 | $27.9 | 95.48% |
| 2023-08-04 | 14 | $73 | $37 | $54.307 | $27.9 | 94.65% |
| 2023-08-07 | 14 | $73 | $37 | $53.692 | $27.9 | 92.44% |
| 2023-08-15 | 13 | $73 | $37 | $52.666 | $27.9 | 88.77% |
| 2023-09-15 | 13 | $73 | $31 | $50.545 | $27.9 | 81.16% |
| 2023-09-17 | 14 | $73 | $30 | $48.909 | $27.9 | 75.3% |
| 2023-09-18 | 14 | $73 | $22 | $43.5 | $27.9 | 55.91% |
| 2023-09-19 | 14 | $73 | $22 | $38.916 | $27.9 | 39.48% |
| 2023-09-20 | 14 | $73 | $22 | $37.416 | $27.9 | 34.11% |
| 2023-10-10 | 14 | $73 | $22 | $35.75 | $27.9 | 28.14% |
| 2023-10-17 | 14 | $73 | $22 | $35.833 | $27.9 | 28.43% |
| 2023-10-20 | 14 | $73 | $22 | $35.416 | $27.9 | 26.94% |
| 2023-10-26 | 14 | $73 | $22 | $35.166 | $27.9 | 26.04% |
| 2023-10-30 | 14 | $56 | $17 | $30.833 | $27.9 | 10.51% |
| 2023-11-21 | 14 | $51 | $17 | $28.25 | $27.9 | 1.25% |
| 2023-12-18 | 15 | $51 | $17 | $28.923 | $27.9 | 3.67% |
| 2023-12-19 | 15 | $51 | $17 | $28.923 | $27.9 | 3.67% |
The Trend in the Analyst Price Target
PTCT's average price target has moved down $26.31 over the prior 172 days.
Over the past 49 weeks, PTCT's average upside potential has been 29.56%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-09 | 12 | 75 | 35 | 54.272 | 45.94 | 18.14% |
| 2023-04-28 | 13 | 75 | 35 | 54.166 | 55.14 | -1.77% |
| 2023-09-20 | 14 | 73 | 22 | 37.416 | 25.53 | 46.56% |
| 2023-10-30 | 14 | 51 | 17 | 28.250 | 18.74 | 50.75% |
| 2023-12-19 | 15 | 51 | 17 | 28.923 | 27.60 | 4.79% |
PTCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.85 | 5 | 0 | 5 | 3 | 3 | 15 |
The Trend in the Broker Recommendations
PTCT's average broker recommendation rating worsened by 0.89 over the prior 15 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how PTC THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -4699.46% of that group.
- To contextualize these metrics, consider that out of all US stocks, PTC THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 4685.95% of them.
- In terms of how PTC THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 4799.94% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PTC THERAPEUTICS INC's average analyst price target is greater than 4386.74% of them.
In the Pharmaceutical Products industry, DVAX, OPK, and AMRN are the three stocks most similar to PTC THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PTCT a Buy, Hold or Sell? See the POWR Ratings now!